Hoth Therapeutics Inc

NASDAQ HOTH

Data sourced from iex and EODHD
Download Data

Hoth Therapeutics Inc Income Statement 2017 - 2023

This table shows the Income Statement for Hoth Therapeutics Inc going from 2017 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Revenue
M 0 0 0 0 0 0 0
Cost of Revenue
M - 0 47 0 0 0 0
Gross Profit
M - 0 -47 0 0 0 0
Operating Expenses
M - 11 -33 7 8 2 2
Selling, General, and Administrative Expenses (SG&A)
M 4 6 7 4 5 1 1
Research and Development (R&D) Expenses
M 3 5 8 3 2 1 1
Other Operating Expenses
M - 0 -47 0 1 0 0
Costs and Expenses
M - 11 -33 7 8 2 3
Operating Income
M -8 -11 -14 -7 -8 -2 -2
Interest Expense
M - 0 0 0 0 0 0
Non-operating Income/Expense
M 0 0 0 0 0 0 0
EBT
M -8 -11 -14 -7 -8 -2 -2
Income Tax Provision
M 0 0 0 0 0 0 0
Income after Tax
M -8 -12 -15 -7 -8 -2 -2
Non-Controlling Interest
M - - 0 0 0 0 0
Net Income
M - - -14 -7 -8 -2 -3
Shares (Basic, Weighted)
M - - - - - - -
Shares (Diluted, Weighted)
R 3,409,190.00 1,197,521.00 893,203.00 494,513.00 366,583.00 376,982.00 9,424,574.00
EBITDA
M -8 -11 -14 -7 -8 -2 -
Depreciation and Amortization
M 8 0 0 0 0 0 -
EBIT
M -15 -11 -14 -7 -8 -2 -3
Income from Discontinued Operations
M - - - - - - -
Tax Rate (Effective)
% 0.10 -2.69 -1.48 1.45 0.13 0.00 0.00
Earnings Per Share (EPS), Basic
M - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0
Gross Profit Margin
% - - - - - - -
Operating Income Margin
% - - - - - - -
Net Income Margin
% - - - - - - -
EBITDA Ratio
% - - - - - - -
EBIT Ratio
% - - - - - - -
EBT Ratio
% - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email